Loading organizations...
Novilytic delivers nanotechnology solutions for biopharmaceutical quality control. Its Proteometer platform uses molecular recognition to precisely monitor protein-based medicine integrity throughout manufacturing. This patented technology enhances analytical reliability and efficiency, providing advanced, comprehensive insights critical for assessing biopharmaceutical product quality.
Founded by Dr. Fred Regnier, an analytical chemist formerly with Purdue University, Novilytic emerged from his insight into the inadequacy of traditional biopharmaceutical analytical methods. Dr. Regnier envisioned applying nanotechnology to create robust monitoring tools, ensuring protein therapeutic quality and efficacy, thus contributing to safer public health.
Novilytic serves the biopharmaceutical industry, supporting R&D and manufacturing processes requiring stringent quality assurance for critical medications. The company's long-term vision is to transform biopharmaceutical analytics with rapid, accurate, and comprehensive tools. This ensures consistently high-quality and safer therapeutic proteins are delivered to patients.
Novilytic has raised $2.0M across 1 funding round.
Novilytic has raised $2.0M in total across 1 funding round.
Novilytic has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2022 | $2M Seed | — | Elevate Ventures | Announced |
Novilytic has raised $2.0M in total across 1 funding round.
Novilytic's investors include Elevate Ventures.
Novilytic is a biochemistry analytics company that builds the Proteometer platform for rapid, near‑real‑time protein quality testing in pharmaceutical development and bioreactor monitoring[5]. Novilytic’s tools are designed to let scientists measure titer, aggregates, and charge variants from clarified fermentation broth or other samples in minutes without extensive sample prep or method development[5][4].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick tie back: Novilytic applies a “canary in the fermentor” ethos—packaging patented nanoparticle‑based assays into consumables that bring fast, actionable protein quality data directly to scientists, addressing a persistent bottleneck in biologics development and biomanufacturing[2][5].